{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:25:44Z","timestamp":1791890744313,"version":"4.3.4"},"reference-count":57,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T00:00:00Z","timestamp":1712102400000},"content-version":"vor","delay-in-days":2618,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Medicine"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.7861\/clinmedicine.17-1-71","type":"journal-article","created":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T04:05:17Z","timestamp":1485921917000},"page":"71-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":129,"title":["Behcet\u2019s disease"],"prefix":"10.1016","volume":"17","author":[{"given":"Jagdish R","family":"Nair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J","family":"Moots","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.7861\/clinmedicine.17-1-71_bib1","first-page":"1152","article-title":"Uber rezidiverendeaphthose durch ein virus verursachte Geschwure am Mund, am Auge, und an den Genitalien","volume":"105","author":"Behcet","year":"1937","journal-title":"Dermatol Wochenschr"},{"key":"10.7861\/clinmedicine.17-1-71_bib2","first-page":"820","article-title":"The prevalence of Behcet\u2019s syndrome in a rural area in northern Turkey","volume":"15","author":"Yurdakul","year":"1988","journal-title":"J Rheumatol"},{"key":"10.7861\/clinmedicine.17-1-71_bib3","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1136\/ard.36.6.491","article-title":"Beh\u00e7et syndrome in 32 patients in Yorkshire","volume":"36","author":"Chamberlain","year":"1977","journal-title":"Ann Rheum Dis"},{"key":"10.7861\/clinmedicine.17-1-71_bib4","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/ard.39.4.344","article-title":"HLA antigens in Beh\u00e7et\u2019s disease: a reappraisal by a comparative study of Turkish and British patients","volume":"39","author":"Yazici","year":"1980","journal-title":"Ann Rheum Dis"},{"key":"10.7861\/clinmedicine.17-1-71_bib5","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/ng.625","article-title":"Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Beh\u00e7et\u2019s disease","volume":"42","author":"Remmers","year":"2010","journal-title":"Nat Genet"},{"key":"10.7861\/clinmedicine.17-1-71_bib6","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/ng.624","article-title":"Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Beh\u00e7et\u2019s disease susceptibility loci","volume":"42","author":"Mizuki","year":"2010","journal-title":"Nat Genet"},{"key":"10.7861\/clinmedicine.17-1-71_bib7","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/ng.2520","article-title":"Genome-wide association analysis identifies new susceptibility loci for Beh\u00e7et\u2019s disease and epistasis between HLA-B*51 and ERAP1.","volume":"45","author":"Kirino","year":"2013","journal-title":"Nat Genet"},{"issue":"Suppl 42","key":"10.7861\/clinmedicine.17-1-71_bib8","first-page":"14","article-title":"Revision of the International Criteria for Behcet\u2019s Disease (ICBD)","volume":"24","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"10.7861\/clinmedicine.17-1-71_bib9","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/jdv.12107","article-title":"The International Criteria for Beh\u00e7et\u2019s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria","volume":"28","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.7861\/clinmedicine.17-1-71_bib10","first-page":"1078","article-title":"Criteria for diagnosis of Beh\u00e7et\u2019s disease. International Study Group for Beh\u00e7et\u2019s Disease","volume":"335","year":"1990","journal-title":"Lancet"},{"key":"10.7861\/clinmedicine.17-1-71_bib11","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1007\/s00415-013-7209-3","article-title":"Diagnosis and management of Neuro-Beh\u00e7et\u2019s disease: international consensus recommendations","volume":"261","author":"Kalra","year":"2014","journal-title":"J Neurol"},{"key":"10.7861\/clinmedicine.17-1-71_bib12","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ajo.2004.03.022","article-title":"Uveitis in Beh\u00e7et disease: an analysis of 880 patients","volume":"138","author":"Tugal-Tutkun","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.7861\/clinmedicine.17-1-71_bib13","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.0001-6349.2005.00761.x","article-title":"Beh\u00e7et\u2019s disease and pregnancy","volume":"84","author":"Jadaon","year":"2005","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.7861\/clinmedicine.17-1-71_bib14","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1111\/jog.12386","article-title":"Behcet\u2019s disease and pregnancy: a retrospective analysis of course of disease and pregnancy outcome","volume":"40","author":"Iskender","year":"2014","journal-title":"J Obstet Gynaecol Res"},{"issue":"Suppl 2","key":"10.7861\/clinmedicine.17-1-71_bib15","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1136\/annrheumdis-2015-eular.3438","article-title":"Behcet\u2019s disease and pregnancy: what is the relationship?","volume":"74","author":"Gilio","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.7861\/clinmedicine.17-1-71_bib16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0007-0971(59)80106-6","article-title":"Segmental pulmonary artery aneurysms with peripheral venous thrombosis","volume":"53","author":"Hughes","year":"1959","journal-title":"Br J Dis Chest"},{"key":"10.7861\/clinmedicine.17-1-71_bib17","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1136\/ard.2007.080432","article-title":"EULAR recommendations for the management of Beh\u00e7et disease","volume":"67","author":"Hatemi","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.7861\/clinmedicine.17-1-71_bib18","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1056\/NEJMoa1408684","article-title":"Apremilast for Behcet\u2019s syndrome \u2014 A phase 2, placebo-controlled study","volume":"372","author":"Hatemi","year":"2015","journal-title":"N Engl J Med"},{"key":"10.7861\/clinmedicine.17-1-71_bib19","doi-asserted-by":"crossref","first-page":"284","DOI":"10.7326\/0003-4819-149-4-200808190-00018","article-title":"\u201cResistant Beh\u00e7et disease responsive to anakinra.\u201d","volume":"149","author":"Botsios","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.7861\/clinmedicine.17-1-71_bib20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000358125","article-title":"Inhibition of Interleukin-1 by canakinumab as a successful mono-drug strategy for the treatment of refractory Beh\u00e7et\u2019s disease: a case series","volume":"228","author":"Vitale","year":"2014","journal-title":"Dermatology"},{"key":"10.7861\/clinmedicine.17-1-71_bib21","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3109\/s10165-011-0497-5","article-title":"A case of Beh\u00e7et\u2019s disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab","author":"Hirano","year":"2012","journal-title":"Modern Rheumatology"},{"key":"10.7861\/clinmedicine.17-1-71_bib22","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1136\/annrheumdis-2012-202392","article-title":"Successful long-term triple disease control by ustekinumab in a patient with Beh\u00e7et\u2019s disease, psoriasis and hidradenitis suppurativa","volume":"72","author":"Baerveldt","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.7861\/clinmedicine.17-1-71_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD011018","article-title":"Interventions for the management of oral ulcers in Beh\u00e7et\u2019s disease","author":"Taylor","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.7861\/clinmedicine.17-1-71_bib24","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1002\/1529-0131(200111)44:11<2686::AID-ART448>3.0.CO;2-H","article-title":"A double-blind trial of colchicine in Beh\u00e7et\u2019s syndrome","volume":"44","author":"Yurdakul","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.7861\/clinmedicine.17-1-71_bib25","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1056\/NEJM199002013220501","article-title":"A controlled trial of azathioprine in Beh\u00e7et\u2019s syndrome","volume":"322","author":"Yazici","year":"1990","journal-title":"N Engl J Med"},{"key":"10.7861\/clinmedicine.17-1-71_bib26","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/art.1780400425","article-title":"Azathioprine in Beh\u00e7et\u2019s syndrome: effects on long-term prognosis","volume":"40","author":"Hamuryudan","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.7861\/clinmedicine.17-1-71_bib27","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1346-8138.2002.tb00263.x","article-title":"Dapsone in Beh\u00e7et\u2019s disease: a double-blind, placebo-controlled, cross-over study","volume":"29","author":"Sharquie","year":"2002","journal-title":"J Dermatol"},{"key":"10.7861\/clinmedicine.17-1-71_bib28","first-page":"98","article-title":"Short-term trial of Etanercept in Behcet\u2019s disease: a double blind, placebo controlled study","volume":"32","author":"Melikoglu","year":"2005","journal-title":"J Rheumatol"},{"key":"10.7861\/clinmedicine.17-1-71_bib29","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/rheumatology\/41.10.1213-c","article-title":"Beh\u00e7et\u2019s syndrome: response to infliximab after failure of etanercept","volume":"41","author":"Estrach","year":"2002","journal-title":"Rheumatology"},{"key":"10.7861\/clinmedicine.17-1-71_bib30","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.semarthrit.2010.09.002","article-title":"Anti-TNF agents for Behcet\u2019s disease: analysis of published data on 369 patients","volume":"41","author":"Arida","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.7861\/clinmedicine.17-1-71_bib31","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/art.23345","article-title":"Infliximab for the treatment of Neuro-Beh\u00e7et\u2019s disease: a case series and review of the literature","volume":"59","author":"Pipitone","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.7861\/clinmedicine.17-1-71_bib32","article-title":"Treatment of Neuro Beh\u00e7et\u2019s disease with infliximab","volume":"28","author":"Al-Araji","year":"2010","journal-title":"An international multi-centre case-series of 18 patients. Clin Exp Rheumatol"},{"key":"10.7861\/clinmedicine.17-1-71_bib33","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jneuroim.2011.08.014","article-title":"Infliximab monotherapy in neuro-Beh\u00e7et\u2019s disease: four year follow-up in a long-standing case resistant to conventional therapies","volume":"239","author":"Fasano","year":"2011","journal-title":"J Neuroimmunol"},{"key":"10.7861\/clinmedicine.17-1-71_bib35","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1001\/archderm.138.4.467","article-title":"Interferon \u03b1-2a in the treatment of Beh\u00e7et disease: a randomized placebo-controlled and double-blind study","volume":"138","author":"Alpsoy","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.7861\/clinmedicine.17-1-71_bib36","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.semarthrit.2003.09.005","article-title":"Differential efficacy of human recombinant interferon-\u03b12a on ocular and extraocular manifestations of Beh\u00e7et disease: results of an open 4-center trial","volume":"33","author":"Kotter","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"10.7861\/clinmedicine.17-1-71_bib37","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1076\/ocii.8.4.293.6453","article-title":"Efficacy of interferon \u03b1-2a in severe and refractory uveitis associated with Beh\u00e7et\u2019s disease","volume":"8","author":"Wechsler","year":"2000","journal-title":"Ocul Immunol Inflamm"},{"key":"10.7861\/clinmedicine.17-1-71_bib38","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1136\/bjo.2006.101550","article-title":"Efficacy of interferon \u03b1 in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patients","volume":"91","author":"Bodaghi","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.7861\/clinmedicine.17-1-71_bib39","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.semarthrit.2003.09.010","article-title":"The use of interferon \u03b1 in Beh\u00e7et disease: review of the literature","volume":"33","author":"Kotter","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"10.7861\/clinmedicine.17-1-71_bib40","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1136\/annrheumdis-2014-205571","article-title":"Pegylated interferon-\u03b1-2b reduces corticosteroid requirement in patients with Beh\u00e7et\u2019s disease with upregulation of circulating regulatory T cells and reduction of Th17","volume":"74","author":"Lightman","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.7861\/clinmedicine.17-1-71_bib41","first-page":"443","article-title":"Thalidomide in the treatment of the mucocutaneous lesions of the Behcet syndrome","volume":"128","author":"Hamuryudan","year":"1998","journal-title":"A randomized, double-blind, placebo-controlled trial. Ann Intern Med"},{"issue":"Suppl 4","key":"10.7861\/clinmedicine.17-1-71_bib42","first-page":"136","article-title":"Evaluation of conventional therapy versus cyclosporine A in Beh\u00e7et\u2019s syndrome","volume":"20","author":"BenEzra","year":"1988","journal-title":"Transplant Proc"},{"key":"10.7861\/clinmedicine.17-1-71_bib43","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1756-185X.2010.01546.x","article-title":"Rituximab in intractable ocular lesions of Behcet\u2019s disease; randomized single-blind control study (pilot study)","volume":"13","author":"Davatchi","year":"2010","journal-title":"Int J Rheum Dis"},{"key":"10.7861\/clinmedicine.17-1-71_bib44","first-page":"152","article-title":"Abdominal aortic aneurysm in Beh\u00e7et\u2019s disease: new treatment options for an old and challenging problem","volume":"6","author":"Nitecki","year":"2004","journal-title":"Isr Med Assoc J"},{"key":"10.7861\/clinmedicine.17-1-71_bib45","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1148\/radiol.2203001418","article-title":"Aortic and arterial aneurysms in Beh\u00e7et disease: management with stent-grafts \u2013 initial experience","volume":"220","author":"Park","year":"2001","journal-title":"Radiology"},{"key":"10.7861\/clinmedicine.17-1-71_bib46","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jvs.2005.03.019","article-title":"Long-term outcome after surgical treatment of arterial lesions in Beh\u00e7et disease","volume":"42","author":"Hosaka","year":"2005","journal-title":"J Vasc Surg"},{"key":"10.7861\/clinmedicine.17-1-71_bib47","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/MD.0000000000000494","article-title":"Beh\u00e7et disease with vascular involvement: effects of different therapeutic regimens on the incidence of new relapses","volume":"94","author":"Alibaz-Oner","year":"2015","journal-title":"Medicine"},{"key":"10.7861\/clinmedicine.17-1-71_bib48","unstructured":"48 Optimal utilisation of biologic drugs in Beh\u00e7et\u2019s Disease: a randomised controlled trial of infliximab (IFX) verses alpha interferon (aIFN), with genotyping and metabolomic profiling, towards a stratified medicines approach to treatment. www.hra.nhs.uk\/news\/research-summaries\/bio-behcets\/ [Accessed 20 December 2016].,"},{"key":"10.7861\/clinmedicine.17-1-71_bib49","first-page":"1","article-title":"Pregnancy outcome after in utero exposure to colchicine","volume":"203:144","author":"Diav-Citrin","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.7861\/clinmedicine.17-1-71_bib50","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1080\/10428190802474447","article-title":"Treatment of Beh\u00e7et\u2019s syndrome and plasmacytoma in a patient with peripheral blood stem cell transplantation","volume":"49","author":"Chauhan","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"10.7861\/clinmedicine.17-1-71_bib51","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1093\/rheumatology\/ket479","article-title":"Bone marrow transplantation for Beh\u00e7et\u2019s disease: a case report and systematic review of the literature","volume":"53","author":"Soysal","year":"2014","journal-title":"Rheumatology"},{"key":"10.7861\/clinmedicine.17-1-71_bib52","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3324\/haematol.2009.013458","article-title":"Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years\u2019 experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases","volume":"95","author":"Farge","year":"2010","journal-title":"Haematologica"},{"key":"10.7861\/clinmedicine.17-1-71_bib53","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/rheumatology\/38.8.728","article-title":"Behcet\u2019s disease: evaluation of a new instrument to measure clinical activity","volume":"38","author":"Bhakta","year":"1999","journal-title":"Rheumatology"},{"key":"10.7861\/clinmedicine.17-1-71_bib54","first-page":"931","article-title":"Development of the BD-QoL: a quality of life measure specific to Behcet\u2019s disease","volume":"31","author":"Gilworth","year":"2004","journal-title":"J Rheumatol"},{"key":"10.7861\/clinmedicine.17-1-71_bib55","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/j.1600-0714.2009.00803.x","article-title":"A composite index for determining the impact of oral ulcer activity in Behcet\u2019s disease and recurrent aphthous stomatitis","volume":"38","author":"Mumcu","year":"2009","journal-title":"J Oral Pathol Med"},{"key":"10.7861\/clinmedicine.17-1-71_bib56","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1161\/01.STR.19.12.1497","article-title":"Modification of Rankin scale: recovery of motor function after stroke","volume":"19","author":"Bonita","year":"1988","journal-title":"Stroke"},{"key":"10.7861\/clinmedicine.17-1-71_bib57","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1002\/art.27568","article-title":"Mortality in Behcet\u2019s disease","volume":"62","author":"Saadoun","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.7861\/clinmedicine.17-1-71_bib34","first-page":"54","article-title":"Efficacy of adalimumab in patients with Beh\u00e7et\u2019s disease unsuccessfully treated with infliximab","volume":"29","author":"Olivieri","year":"2011","journal-title":"Clin Exp Rheumatol"}],"container-title":["Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211824023170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211824023170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.7861\/clinmedicine.17-1-71","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T06:36:14Z","timestamp":1761460574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1470211824023170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S1470211824023170"],"URL":"https:\/\/doi.org\/10.7861\/clinmedicine.17-1-71","relation":{},"ISSN":["1470-2118"],"issn-type":[{"value":"1470-2118","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Behcet\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.7861\/clinmedicine.17-1-71","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 Royal College of Physicians 2017. All rights reserved.","name":"copyright","label":"Copyright"}]}}